Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

IRadimed Corp
NASDAQ:IRMD

Watchlist Manager
IRadimed Corp Logo
IRadimed Corp
NASDAQ:IRMD
Watchlist
Price: 82.86 USD 0.78% Market Closed
Market Cap: $1.1B
Write Note Create Alert Ask AI

Wall St Price Targets

IRMD Price Targets Summary
IRadimed Corp

Wall Street analysts forecast IRMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IRMD is 120.36 USD with a low forecast of 117.16 USD and a high forecast of 126 USD.

IRMD Lowest Forecast
Wall Street Target
$117.16
41% Upside
IRMD Average Forecast
Wall Street Target
$120.36
45% Upside
IRMD Highest Forecast
Wall Street Target
$126
52% Upside
Lowest Forecast
Price Target
117.16 USD
41% Upside
Average Forecast
Price Target
120.36 USD
45% Upside
Highest Forecast
Price Target
126 USD
52% Upside
IRadimed Corp Competitors:
Price Targets

Revenue
Forecast

18% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
18% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 12 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 3 years is 11%.

What are analyst estimates?

Gross Profit
Forecast

18% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
18% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 12 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 12%.

What are analyst estimates?

Operating Income
Forecast

20% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
20% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 12 years, the compound annual growth rate for Operating Income has been 20%. The projected CAGR for the next 3 years is 13%.

What are analyst estimates?

Pre-Tax Income
Forecast

21% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
21% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 12 years, the compound annual growth rate for Pre-Tax Income has been 21%. The projected CAGR for the next 3 years is 16%.

What are analyst estimates?

Net Income
Forecast

23% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
23% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 12 years, the compound annual growth rate for Net Income has been 23%. The projected CAGR for the next 3 years is 16%.

What are analyst estimates?

Continue IRMD Research

Summary
IRMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
IRMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IRMD stock valuation using valuation multiples.
Wall St Estimates
IRMD price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IRMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other IRadimed Corp listings:
F • EUR
46K
 SWB • EUR
46K
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is IRMD's stock price target?
Price Target
120.36 USD

According to Wall Street analysts, the average 1-year price target for IRMD is 120.36 USD with a low forecast of 117.16 USD and a high forecast of 126 USD.

What is the Revenue forecast for IRadimed Corp?
Projected CAGR
11%

Over the last 12 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 3 years is 11%.

What is the Gross Profit forecast for IRadimed Corp?
Projected CAGR
12%

Over the last 12 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 12%.

What is the Operating Income forecast for IRadimed Corp?
Projected CAGR
13%

Over the last 12 years, the compound annual growth rate for Operating Income has been 20%. The projected CAGR for the next 3 years is 13%.

What is the Pre-Tax Income forecast for IRadimed Corp?
Projected CAGR
16%

Over the last 12 years, the compound annual growth rate for Pre-Tax Income has been 21%. The projected CAGR for the next 3 years is 16%.

What is the Net Income forecast for IRadimed Corp?
Projected CAGR
16%

Over the last 12 years, the compound annual growth rate for Net Income has been 23%. The projected CAGR for the next 3 years is 16%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.